Is insulin resistance atherogenic? Possible mechanisms

This publication has 36 references indexed in Scilit:

• Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
  Journal of Clinical Endocrinology & Metabolism, 2004
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Diabetes trends in the U.S.: 1990-1998.
  Diabetes Care, 2000
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
  BMJ, 2000
• Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
  New England Journal of Medicine, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
  Journal of Clinical Endocrinology & Metabolism, 1998
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
  Journal of Clinical Investigation, 1989
• Status of risk factors and their consideration in antihypertensive therapy
  The American Journal of Cardiology, 1987